Dr. Robert M. Kottmann, MD

Dr. Kottmann practices at Smh Infusion Center at Highland Hos - Outpatient Oncology at Hh - HOPD in Rochester, New York.

Dr. Kottmann's NPI, 1073620738, was assigned on August 25, 2006. Dr. Kottmann graduated from Sidney Kimmel Medical College at Thomas Jefferson University in 2001. Dr. Kottmann holds New York license 230874.

Dr. Kottmann's primary practice is Smh Infusion Center at Highland Hos - Outpatient Oncology at Hh - HOPD, at 1000 South Ave, Rochester, NY 14620.

Dr. Kottmann's primary practice is Smh Infusion Center at Highland Hos - Outpatient Oncology at Hh - HOPD in Rochester, New York. Dr. Kottmann is also affiliated with Highland Hospital. The medical group on file is University of Rochester Medical Faculty Group (URMFG). Dmand AI also links Dr. Kottmann to 1 more hospital, 3 group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kottmann practices, 6 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Kottmann's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Kottmann is board certified in internal medicine by the American Board of Internal Medicine. Dr. Kottmann is licensed in New York.

CMS data shows 311 Medicare services from Dr. Kottmann across 8 procedure codes in 2024, for 113 Medicare patients. Medicare paid $30,120 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 113 Medicare patients who saw Dr. Kottmann in 2024. The largest group is under 65, with 36 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 37% are also on Medicaid. Their average risk score is 2.22, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kottmann's median patient age at 72, with 53% women.

In 2024, Dr. Kottmann wrote 416 Medicare Part D claims for 81 patients. 67% of them were for generic drugs. CMS names the drug for 306 of them, across 11 drugs with 11 or more claims each, at $903,004 in total drug cost. In 2023, CMS named 265 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Kottmann for performance year 2024, reported as part of a group. Dr. Kottmann accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kottmann as offering telehealth.

Dmand AI links 13 papers to Dr. Kottmann, published from 2010 to 2025. 2022 was the busiest year, with 3. The most frequent topics are Idiopathic Pulmonary Fibrosis, Pulmonary Fibrosis and Transforming Growth Factor beta. Dr. Kottmann has published most often in Am J Respir Crit Care Med. Dr. Kottmann's most frequent co-authors are Patricia J. Sime, MD, Daniel Patrick Croft, MD and Michael N. Gurell, MD.

CMS Open Payments shows 4 general payments to Dr. Kottmann from 2 drug and device companies from 2017 to 2020. Education make up the largest share, 54% of the total. CSL Behring paid the most, $52.

Dr. Kottmann graduated from Sidney Kimmel Medical College at Thomas Jefferson University in 2001.